Literature DB >> 1806615

Acute complications in the course of "mild" hyperparathyroidism.

S M Corsello1, G Folli, F Crucitti, S Della Casa, C A Rota, A Tofani, S Colasanti, A Barbarino.   

Abstract

It is generally accepted that some patients affected by mild asymptomatic primary hyperparathyroidism need not be treated with surgery, but may be medically managed without risk. However, our experience regarding 5 of these cases observed in the last two years, suggests a different approach. These patients, initially diagnosed as having mild hyperparathyroidism based on only moderately elevated serum concentrations of calcium and followed medically for years, were referred to us for a sudden worsening of their clinical course. One 35-year-old man presented hemorrhagic gastritis with severe anemia and type II AV block with syncopal attacks. Three women, aged 51, 64 and 65 years, presented with severe hypercalcemia associated with renal failure in two and with marked bone disease in another. In all these cases parathyroid neoplasms were preoperatively localized (by ultrasonography, CT scan and radioactive 201-Tl 99-Tc scan) and surgically removed. Histological examination showed a parathyroid carcinoma in the male patient and single gland enlargements in the three females. A fifth patient, a 65-year-old woman, was referred to us in critical condition: severe hypercalcemia, osteopenia with femur fracture, myocardial infarction and renal failure. She died in a few days, in spite of intensive medical care. These cases suggest that patients with hyperparathyroidism initially diagnosed as "mild" need close medical observation and preferably, in our opinion, should undergo surgery.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1806615     DOI: 10.1007/BF03347126

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  17 in total

1.  Time to end a conservative treatment for mild hyperparathyroidism.

Authors:  J C Stevenson; J A Lynn
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-09

Review 2.  Recent advances in parathyroid hormone research.

Authors:  J F Habener
Journal:  Clin Biochem       Date:  1981-10       Impact factor: 3.281

3.  Asymptomatic primary hyperparathyroidism: treat or follow?

Authors:  S E Hodgson; H Heath
Journal:  Mayo Clin Proc       Date:  1981-08       Impact factor: 7.616

4.  Surgery of hyperparathyroid disease.

Authors:  G W Taylor
Journal:  Br J Surg       Date:  1980-10       Impact factor: 6.939

5.  Primary hyperparathyroidism in the seventies. A decade of change?

Authors:  W Browder; J Rakinic; R Schlecter; E T Krementz
Journal:  Am J Surg       Date:  1983-09       Impact factor: 2.565

6.  Management of asymptomatic hyperparathyroidism.

Authors:  R D Gaz; C A Wang
Journal:  Am J Surg       Date:  1984-04       Impact factor: 2.565

7.  Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community.

Authors:  H Heath; S F Hodgson; M A Kennedy
Journal:  N Engl J Med       Date:  1980-01-24       Impact factor: 91.245

8.  Photon absorptiometric analysis of bone density in primary hyperparathyroidism.

Authors:  C Y Pak; A Stewart; R Kaplan; H Bone; C Notz; R Browne
Journal:  Lancet       Date:  1975-07-05       Impact factor: 79.321

Review 9.  The medical management of primary hyperparathyroidism.

Authors:  J P Bilezikian
Journal:  Ann Intern Med       Date:  1982-02       Impact factor: 25.391

10.  Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow-up.

Authors:  M Palmer; H O Adami; R Bergström; S Jakobsson; G Akerström; S Ljunghall
Journal:  Lancet       Date:  1987-01-10       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.